These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17956663)

  • 1. [Expression of wnt5a gene in hematologic diseases and leukemic cell lines].
    Li ZQ; Si WK; Pan J; Yuan Y; Zou QM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):927-30. PubMed ID: 17956663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation.
    Deng G; Li ZQ; Zhao C; Yuan Y; Niu CC; Zhao C; Pan J; Si WK
    Oncol Rep; 2011 Feb; 25(2):367-76. PubMed ID: 21165581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
    Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor.
    Ying J; Li H; Chen YW; Srivastava G; Gao Z; Tao Q
    Blood; 2007 Dec; 110(12):4130-2. PubMed ID: 18024799
    [No Abstract]   [Full Text] [Related]  

  • 5. Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
    Janovska P; Poppova L; Plevova K; Plesingerova H; Behal M; Kaucka M; Ovesna P; Hlozkova M; Borsky M; Stehlikova O; Brychtova Y; Doubek M; Machalova M; Baskar S; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Clin Cancer Res; 2016 Jan; 22(2):459-69. PubMed ID: 26240275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
    Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
    Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation phenotypes of k562 cells induced by exogenous wnt5a].
    Yuan Y; Si WK; Li ZQ; Pan J; Zhao C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):946-9. PubMed ID: 17956667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of transcription factor GATA-1 and GATA-2 genes in bone marrow stromal cells from patients with leukemia].
    Wu XL; Li YQ; Wang Z; Yang LJ; Chen SH; Zhang H; Zhu KE; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):70-5. PubMed ID: 15748439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a is involved in the pathogenesis of cutaneous lichen planus.
    Zhang Y; Zhang D; Tu C; Zhou P; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
    Clin Exp Dermatol; 2015 Aug; 40(6):659-64. PubMed ID: 25581355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells.
    Fernandez-Cobo M; Zammarchi F; Mandeli J; Holland JF; Pogo BG
    Oncol Rep; 2007 Apr; 17(4):903-7. PubMed ID: 17342334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Wnt5a in tooth germs and the related signal transduction analysis.
    Peng L; Dong G; Xu P; Ren LB; Wang CL; Aragon M; Zhou XD; Ye L
    Arch Oral Biol; 2010 Feb; 55(2):108-14. PubMed ID: 20034610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent up-regulation of WNT5A mRNA in primary gastric cancer.
    Saitoh T; Mine T; Katoh M
    Int J Mol Med; 2002 May; 9(5):515-9. PubMed ID: 11956659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells.
    Saitoh T; Katoh M
    Int J Mol Med; 2002 Sep; 10(3):345-9. PubMed ID: 12165812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Wnt protein expression in chondral constructs from mesenchymal stem cells.
    Nishioka K; Dennis JE; Gao J; Goldberg VM; Caplan AI
    J Cell Physiol; 2005 Apr; 203(1):6-14. PubMed ID: 15389636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
    Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
    Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.